spacer
home > pmps > autumn 2018 > broadening biologics
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Broadening Biologics

In recent years, the pharmaceutical industry has seen a steady shift toward increased patient centricity. The impact can be seen in nearly every aspect of the industry from regulatory guidance, trial design, and drug delivery to new drugs proliferating the pipeline, such as biologics.

Biologics are used to treat chronic conditions, such as multiple sclerosis and other autoimmune diseases. Additionally, by targeting specific components of a disease in ways never thought possible before, these therapies also may help some acute conditions, including certain types of cancer, become manageable chronic conditions.

Biologics are set to experience rapid and transformative growth over the next several years as more drug manufacturers tap into their potential. They are already outpacing the compound annual growth rate of the wider pharma industry, mainly driven by the US (1). Most global spending growth, particularly in developed markets, will be driven by oncology, autoimmune, and diabetes treatments where significant innovations are expected. Industry forecasts predict the global annual spend for autoimmune diseases alone to be US $75-90 billion in 2021 (1).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Victoria Morgan has been in the pharma industry for 25 years with extensive experience in the area of injection drug delivery products, such as primary packaging and combination products for vial, cartridge, and pre-filled syringe systems. Throughout her tenure at West Pharmaceutical Services, Inc, she has served in various functions across sales and marketing. Victoria spent more than 17 years in global sales roles, with her most recent position being Director of Segment Marketing for Biologics, where she has responsibility for global biologic strategy development and implementation.
spacer
Victoria Morgan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PHARM Connect 2019

Life science and business are going to meet at PHARM Connect on the 12-13 of March 2019 in Budapest, Hungary to continue the tradition of providing high calibre, customised professional partnering opportunities for pharma and biotech professionals from Central & Eastern European and beyond and deliver the crucial information they need to excel in their work. The influential annual gathering brings together over 400 global and regional decision-makers, top scientists, industry executives and business development leaders for the ninth time to identify new business opportunities, technologies, state-of-the-art formulation development strategies and to foster exchange of ideas on the role of the sector.
More info >>

White Papers

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology

European Society for Medical Oncology (ESMO)

  The number of cancer patients in Europe is rising and significant advances in basic and applied cancer research are making the provision of optimal care more challenging. The concept of cancer as a systemic, highly heterogeneous and complex disease has increased the awareness that quality cancer care should be provided by a multidisciplinary team (MDT) of highly qualified healthcare professionals. Cancer patients also have the right to benefit from medical progress by receiving optimal treatment from adequately trained and highly skilled medical professionals. Built on the highest standards of professional training and continuing medical education, medical oncology is recognised as an independent medical specialty in many European countries.
More info >>

 
Industry Events

PHARM Connect Congress 2019

12-13 March 2019, Budapest Congress Center, Hungary

PHARM Connect Congress is the premier networking business event dedicated to pharmaceutical and biotechnology innovations and trends from development through commercialisation in Central and Eastern Europe. The organiser - TEG The Events Group - cordially welcome all lead business professionals, academicians, researchers and peers from the field of pharmaceutical manufacturing and biotechnology to participate in the upcoming Congress.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement